Ferroptosis is a form of cell death that has received considerable attention not only as a means to eradicate defined tumour entities but also because it provides unforeseen insights into the metabolic adaptation that tumours exploit to counteract phospholipid oxidation1,2. Here, we identify proferroptotic activity of 7-dehydrocholesterol reductase (DHCR7) and an unexpected prosurvival function of its substrate, 7-dehydrocholesterol (7-DHC). Although previous studies suggested that high concentrations of 7-DHC are cytotoxic to developing neurons by favouring lipid peroxidation3, we now show that 7-DHC accumulation confers a robust prosurvival function in cancer cells. Because of its far superior reactivity towards peroxyl radicals, 7-DHC effectively shields (phospho)lipids from autoxidation and subsequent fragmentation. We provide validation in neuroblastoma and Burkitt's lymphoma xenografts where we demonstrate that the accumulation of 7-DHC is capable of inducing a shift towards a ferroptosis-resistant state in these tumours ultimately resulting in a more aggressive phenotype. Conclusively, our findings provide compelling evidence of a yet-unrecognized antiferroptotic activity of 7-DHC as a cell-intrinsic mechanism that could be exploited by cancer cells to escape ferroptosis.
FörderungenDietmar Hopp Foundation Deutsche Krebshilfe DKTK joint funding project 'RiskY-AML' DFG Deutsche Jose Carreras Leukamie Stiftung (DJCLS) Interdisziplinares Zentrum fur klinische Forschung (IZKF) DFG CRC205 Deutsche Forschungsgemeinschaft (DFG) European Research Council (ERC) German Federal Ministry of Education and Research (BMBF)
NIH National Science Foundation National Institutes of Health NIMH Sao Paulo Research Foundation (FAPESP) Fonds of the Chemical Industry for a Liebig fellowship ERC BMBF VIP+ program NEUROPROTEKT Deutsche Forschungsgemeinschaft Sachsische Aufbaubank SMWK Junior Group Leader programme of the Rudolf Virchow Center, University of Wurzburg